CDMO
GC Signs Definitive Agreement to Acquire US CDMO BioCentriq, Enhancing Global Capabilities
2022-04-19
SK Inc., the Second Largest Conglomerate in South Korea, has invested $350 million in the Center for Breakthrough Medicines
2022-01-11
「毅」新闻 | 毅达资本完成对联创生物近亿元A轮投资
2021-10-27
CDMO企业乐威医药完成近5亿元 C轮融资,盈科资本领投
2021-10-13
高瓴资本1.5亿美元投资金斯瑞蓬勃生物
2021-08-19
昭衍生物完成1.5亿美元B轮融资,全球产能布局再次提速
2021-08-06
首发| 江苏威凯尔医药完成新一轮亿元融资,加速新药研发与CDMO业务布局
2021-07-29
TA Associates Announces Strategic Growth Investment in Elos Medtech
2021-07-27
巨翊科技完成逾亿元人民币B轮融资,加速医疗器械CDMO业务发展
2021-07-14
Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics
2021-07-14
登录医药魔方官网 查看更多资讯